US Patent 8530404 Compounds and methods for treatment of cancer
Patent 8530404 was granted and assigned to Fibrogen, Inc. on September, 2013 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8530404 Compounds and methods for treatment of cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.